The efficacy of Internet-based cognitive behavioral therapy for severely fatigued survivors of breast cancer compared with care as usual: A randomized controlled trial

Fulltext:
176938.pdf
Embargo:
until further notice
Size:
349.3Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2017Source
Cancer, 123, 19, (2017), pp. 3825-3834ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Medical Psychology
Health Evidence
Medical Oncology
Anesthesiology
Journal title
Cancer
Volume
vol. 123
Issue
iss. 19
Page start
p. 3825
Page end
p. 3834
Subject
Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences; Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience; Radboudumc 3: Disorders of movement RIHS: Radboud Institute for Health SciencesAbstract
BACKGROUND: Severe fatigue is a common and distressing symptom affecting approximately one in four survivors of breast cancer. The current study examined the efficacy of Internet-based cognitive behavioral therapy (ICBT) for severe fatigue in survivors of breast cancer compared with care as usual (CAU). METHODS: The authors conducted a parallel-group randomized controlled trial. Severely fatigued, disease-free survivors of breast cancer who had completed cancer treatment at least 3 months previously were eligible. Participants were randomly allocated to ICBT or CAU using computer-generated stratified block randomization. The primary outcome of fatigue severity was assessed at baseline and after 6 months, as were the secondary outcomes of functional impairment, psychological distress, and quality of life. Statistical effects were tested with analyses of covariance (intention-to-treat analysis). RESULTS: Participants were recruited between January 2014 and March 2016 and assigned to ICBT (66 patients) or CAU (66 patients). Compared with the participants who had received CAU, those who had received ICBT reported lower fatigue scores at 6 months (mean difference [Delta], 11.5; 95% confidence interval [95% CI], 7.7-15.3) and a large effect size (Cohen d = 1.0), with the majority of patients (73%) demonstrating clinically significant improvement. ICBT also was found to lead to lower functional impairment (Delta, 297.8; 95% CI, 145.5-450.1) and psychological distress scores (Delta, 5.7; 95% CI, 3.4-7.9) and higher quality-of-life scores (Delta, 11.7; 95% CI, 5.8-17.7) compared with CAU, with medium to large effect sizes (Cohen d = 0.6-0.8). CONCLUSIONS: ICBT appears to be effective in reducing severe fatigue and related symptoms and meets the current need for easy accessible and more efficient evidence-based treatment options for severely fatigued survivors of breast cancer. Cancer 2017;123:3825-34. (c) 2017 American Cancer Society.
This item appears in the following Collection(s)
- Academic publications [227244]
- Electronic publications [108520]
- Faculty of Medical Sciences [86731]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.